Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KT, Edmunds WJ, Frost SD, Funk S, Hollingsworth TD, House T, Isham V, Klepac P, Lessler J, Lloyd-Smith JO, Metcalf CJ, Mollison D, Pellis L, Pulliam JR, Roberts MG, Viboud C; et al.

Modeling infectious disease dynamics in the complex landscape of global health.

Science, 2015; 347: aaa4339. 10.1126/science.aaa4339
Lessler J, Edmunds WJ, Halloran ME, Hollingsworth TD, Lloyd AL.

Seven challenges for model-driven data collection in experimental and observational studies.

Epidemics, 2015; 10: 78-82. 10.1016/j.epidem.2014.12.002
Metcalf CJ, Edmunds WJ, Lessler J.

Six challenges in modelling for public health policy.

Epidemics, 2015; 10: 93-6. 10.1016/j.epidem.2014.08.008
Jones BA, Lessler J, Bianco S, Kaufman JH.

Statistical Mechanics and Thermodynamics of Viral Evolution.

PLoS One, 2015; 10: e0137482. 10.1371/journal.pone.0137482
Pierce RA, Lessler J, Milstone AM.

Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomes.

Curr Opin Infect Dis, 2015; 28: 384-91. 10.1097/QCO.0000000000000179
Grabowski MK, Kigozi G, Gray RH, Armour B, Manucci J, Serwadda D, Redd AD, Nalugoda F, Patel EU, Wawer MJ, Quinn TC, Tobian AA.

Herpes Simplex [corrected] Virus Type 2 Shedding From Male Circumcision Wounds in Rakai, Uganda.

J Infect Dis, 2015; 212: 1613-7. 10.1093/infdis/jiv259
Gianella S, Redd AD, Grabowski MK, Tobian AA, Serwadda D, Newell K, Patel EU, Kalibbala S, Ssebbowa P, Gray RH, Quinn TC, Reynolds SJ.

Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.

J Infect Dis, 2015; 212: 899-903. 10.1093/infdis/jiv135
Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AA.

Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.

Lancet Glob Health, 2015; 3: e478-86. 10.1016/S2214-109X(15)00086-8
Li T, Eappen AG, Richman AM, Billingsley PF, Abebe Y, Li M, Padilla D, Rodriguez-Barraquer I, Sim BK, Hoffman SL.

Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.

Malar J, 2015; 14: 150. 10.1186/s12936-015-0665-8
Moore SM, Lessler J.

Optimal allocation of the limited oral cholera vaccine supply between endemic and epidemic settings.

J R Soc Interface, 2015; 12: 20150703. 10.1098/rsif.2015.0703
Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, Roque VG Jr, Salje H, Macareo LR, Hermann LL, Nisalak A, Srikiatkhachorn A.

High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.

PLoS Negl Trop Dis, 2015; 9: e0003764. 10.1371/journal.pntd.0003764
Levy JW, Bhoomiboonchoo P, Simasathien S, Salje H, Huang A, Rangsin R, Jarman RG, Fernandez S, Chonticha K, Kittinun H, Gibbons RV, Yoon IK.

Elevated transmission of upper respiratory illness among new recruits in military barracks in Thailand.

Influenza Other Respir Viruses, 2015; : . 10.1111/irv.12345
Erasmus JH, Needham J, Raychaudhuri S, Diamond MS, Beasley DW, Morkowski S, Salje H, Fernandez Salas I, Kim DY, Frolov I, Nasar F, Weaver SC.

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection.

PLoS Negl Trop Dis, 2015; 9: e0004119. 10.1371/journal.pntd.0004119
Azman AS, Lessler J.

Reactive vaccination in the presence of disease hotspots.

Proc Biol Sci, 2015; 282: 20141341. 10.1098/rspb.2014.1341
Azman AS, Legros D, Lessler J, Luquero FJ, Moore SM.

Outbreaks of cholera in the time of Ebola: pre-emptive action needed.

Lancet, 2015; 385: 851. 10.1016/S0140-6736(15)60178-7
Azman AS, Luquero FJ, Ciglenecki I.

Long-term efficacy of a hepatitis E vaccine.

N Engl J Med, 2015; 372: 2265. 10.1056/NEJMc1504302#SA1
Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J.

The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.

PLoS Med, 2015; 12: e1001867. 10.1371/journal.pmed.1001867
Abubakar A, Azman AS, Rumunu J, Ciglenecki I, Helderman T, West H, Lessler J, Sack DA, Martin S, Perea W, Legros D, Luquero FJ.

The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan.

PLoS Med, 2015; 12: e1001901. 10.1371/journal.pmed.1001901
Azman AS, Lessler J, Satter SM, Mckay MV, Khan A, Ahmed D, Gurley ES.

Tracking Cholera through Surveillance of Oral Rehydration Solution Sales at Pharmacies: Insights from Urban Bangladesh.

PLoS Negl Trop Dis, 2015; 9: e0004230. 10.1371/journal.pntd.0004230
Kasaie P, Mathema B, Kelton WD, Azman AS, Pennington J, Dowdy DW.

A Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data Collection.

PLoS One, 2015; 10: e0144137. 10.1371/journal.pone.0144137
Tobian AA, Kigozi G, Manucci J, Grabowski MK, Serwadda D, Musoke R, Redd AD, Nalugoda F, Reynolds SJ, Kighoma N, Laeyendecker O, Lessler J, Gray RH, Quinn TC, Wawer MJ; Rakai Health Sciences Program.

HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study.

PLoS Med, 2015; 12: e1001820. 10.1371/journal.pmed.1001820
Takahashi S, Metcalf CJ, Ferrari MJ, Moss WJ, Truelove SA, Tatem AJ, Grenfell BT, Lessler J.

Reduced vaccination and the risk of measles and other childhood infections post-Ebola.

Science, 2015; 347: 1240-2. 10.1126/science.aaa3438
Truelove SA, Moss WJ, Lessler J.

Mitigating measles outbreaks in West Africa post-Ebola.

Expert Rev Anti Infect Ther, 2015; 13: 1299-301. 10.1586/14787210.2015.1085305
Althouse BM, Hanley KA, Diallo M, Sall AA, Ba Y, Faye O, Diallo D, Watts DM, Weaver SC, Cummings DA.

Impact of climate and mosquito vector abundance on sylvatic arbovirus circulation dynamics in Senegal.

Am J Trop Med Hyg, 2015; 92: 88-97. 10.4269/ajtmh.13-0617
Reich NG, Cummings DA, Lauer SA, Zorn M, Robinson C, Nyquist AC, Price CS, Simberkoff M, Radonovich LJ, Perl TM.

Triggering interventions for influenza: the ALERT algorithm.

Clin Infect Dis, 2015; 60: 499-504. 10.1093/cid/ciu749
Kucharski AJ, Lessler J, Read JM, Zhu H, Jiang CQ, Guan Y, Cummings DA, Riley S.

Estimating the life course of influenza AH3N2 antibody responses from cross-sectional data.

PLoS Biol, 2015; 13: e1002082. 10.1371/journal.pbio.1002082
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Ferguson N, Burke DS, Cummings DA.

Differential efficacy of dengue vaccine by immune status.

Lancet, 2015; 385: 1726. 10.1016/S0140-6736(15)60889-3
van Panhuis WG, Choisy M, Xiong X, Chok NS, Akarasewi P, Iamsirithaworn S, Lam SK, Chong CK, Lam FC, Phommasak B, Vongphrachanh P, Bouaphanh K, Rekol H, Hien NT, Thai PQ, Duong TN, Chuang JH, Liu YL, Ng LC, Shi Y, Tayag EA, Roque VG Jr, Suy LLL, Jarman RG, Gibbons RV, Velasco JMS, Yoon IK, Burke DS, Cummings DAT.

Region-wide synchrony and traveling waves of dengue across eight countries in Southeast Asia.

Proc Natl Acad Sci U S A, 2015; 112: 13069-74. 10.1073/pnas.1501375112
Mazet JA, Wei Q, Zhao G, Cummings DA, Desmond JS, Rosenthal J, King CH, Cao W, Chmura AA, Hagan EA, Zhang S, Xiao X, Xu J, Shi Z, Feng F, Liu X, Pan W, Zhu G, Zuo L, Daszak P.

Joint China-US Call for Employing a Transdisciplinary Approach to Emerging Infectious Diseases.

Ecohealth, 2015; 12: 555-9. 10.1007/s10393-015-1060-1
Clapham H, Cummings DA, Nisalak A, Kalayanarooj S, Thaisomboonsuk B, Klungthong C, Fernandez S, Srikiatkhachorn A, Macareo LR, Lessler J, Reiser J, Yoon IK.

Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics.

PLoS Negl Trop Dis, 2015; 9: e0004262. 10.1371/journal.pntd.0004262
Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O.

Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

AIDS Res Hum Retroviruses, 2014; 30(4): 339-44. 10.1089/AID.2013.0169
Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH.

HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.

J Clin Microbiol, 2014; 52(1): 115-21. 10.1128/JCM.02040-13
Longosz AF, Mehta SH, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O.

Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.

AIDS, 2014; 28(8): 1227-32. 10.1097/QAD.0000000000000221.
Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O.

Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

J Acquir Immune Defic Syndr, 2014; 65(4): 390-396. 10.1097/QAI.0000000000000006
Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Kobin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH.

A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.

PLoS One, 2014; 9(6): e101043. 10.1371/journal.pone.0101043
Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szekeres G, Donnell D, Eshleman SH; NIMH Project Accept (HPTN 043) study team.

Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial.

Lancet Glob Health, 2014; 2(5): e267-277. 10.1016/S2214-109X(14)70032-4
Huynh D, Laeyendecker O, Brookmeyer R.

A serial risk score approach to disease classification that accounts for accuracy and cost.

Biometrics, 2014; 70(4): 1042-1051. 10.1111/biom.12217
Laeyendecker O, Brookmeyer R.

Response to using incidence assays within the context of the recent infections testing algorithm.

AIDS, 2014; 28(14): 2168. 10.1097/QAD.0000000000000368
Etemad B, Gonzalez OA, White L, Laeyendecker O, Kirk GD, Mehta S, Sagar M.

Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.

Retrovirology, 2014; 11: 106. 10.1186/s12977-014-0106-8
Ng OT, Laeyendecker O, Redd AD, Munshaw S, Grabowski MK, Paquet AC, Evans MC, Haddad M, Huang W, Robb ML, Reynolds SJ, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, Quinn TC.

HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.

J Infect Dis, 2014; 209(1): 67-73. 10.1093/infdis/jit425.